These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32705459)

  • 1. 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.
    Thomas S; Johnson JA; Xie F
    Qual Life Res; 2020 Nov; 29(11):3109-3118. PubMed ID: 32705459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
    Jyani G; Yang Z; Sharma A; Goyal A; Stolk E; Purba FD; Grover S; Kaur M; Prinja S
    Med Decis Making; 2023 Aug; 43(6):692-703. PubMed ID: 37480281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets.
    Che M; Xie F; Thomas S; Pullenayegum E
    Med Decis Making; 2023 Jul; 43(5):587-594. PubMed ID: 37243474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review.
    Poudel N; Fahim SM; Qian J; Garza K; Chaiyakunapruk N; Ngorsuraches S
    J Med Econ; 2022; 25(1):571-582. PubMed ID: 35416095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Graczyk K; Niewada M
    Pharmacoeconomics; 2019 Sep; 37(9):1165-1176. PubMed ID: 31161586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
    Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating a Multiply Imputed Value Set for the EQ-5D-5L in Canada: State-Level Misspecification Terms Are Needed to Characterize Parameter Uncertainty Correctly.
    Tsui TCO; Chan KKW; Xie F; Pullenayegum EM
    Med Decis Making; 2024 May; 44(4):405-414. PubMed ID: 38591189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.
    Ludwig K; von der Schulenburg JG; Greiner W
    Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study.
    Al Sayah F; Johnson JA; Ohinmaa A; Xie F; Bansback N;
    Qual Life Res; 2017 Jun; 26(6):1483-1492. PubMed ID: 28124280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination for EQ-5D-5L value set studies.
    Gandhi M; Xu Y; Luo N; Cheung YB
    Qual Life Res; 2017 Dec; 26(12):3365-3376. PubMed ID: 28825183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EQ-5D-5L Valuation study in Thailand.
    Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y
    Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L.
    Karim S; Craig BM; Groothuis-Oudshoorn CGM
    Health Qual Life Outcomes; 2022 May; 20(1):85. PubMed ID: 35614472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.
    Rand-Hendriksen K; Ramos-Goñi JM; Augestad LA; Luo N
    Value Health; 2017; 20(7):945-952. PubMed ID: 28712624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.
    Ramos-Goñi JM; Pinto-Prades JL; Oppe M; Cabasés JM; Serrano-Aguilar P; Rivero-Arias O
    Med Care; 2017 Jul; 55(7):e51-e58. PubMed ID: 25521503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.